161 related articles for article (PubMed ID: 31069006)
21. Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma.
Ushiku H; Yamashita K; Katoh H; Ema A; Minatani N; Kikuchi M; Kojo K; Yokoi K; Tanaka T; Nishizawa N; Ishii S; Hosoda K; Moriya H; Mieno H; Katada N; Kikuchi S; Watanabe M
Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27629777
[TBL] [Abstract][Full Text] [Related]
22. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.
Brait M; Ling S; Nagpal JK; Chang X; Park HL; Lee J; Okamura J; Yamashita K; Sidransky D; Kim MS
PLoS One; 2012; 7(9):e44951. PubMed ID: 23028699
[TBL] [Abstract][Full Text] [Related]
23. CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.
Meller S; Zipfel L; Gevensleben H; Dietrich J; Ellinger J; Majores M; Stein J; Sailer V; Jung M; Kristiansen G; Dietrich D
Epigenetics; 2016 Dec; 11(12):871-880. PubMed ID: 27689475
[TBL] [Abstract][Full Text] [Related]
24. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
25. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.
Tamura G; Yin J; Wang S; Fleisher AS; Zou T; Abraham JM; Kong D; Smolinski KN; Wilson KT; James SP; Silverberg SG; Nishizuka S; Terashima M; Motoyama T; Meltzer SJ
J Natl Cancer Inst; 2000 Apr; 92(7):569-73. PubMed ID: 10749913
[TBL] [Abstract][Full Text] [Related]
26. Aberrant methylation of Reprimo in human malignancies.
Takahashi T; Suzuki M; Shigematsu H; Shivapurkar N; Echebiri C; Nomura M; Stastny V; Augustus M; Wu CW; Wistuba II; Meltzer SJ; Gazdar AF
Int J Cancer; 2005 Jul; 115(4):503-10. PubMed ID: 15700311
[TBL] [Abstract][Full Text] [Related]
27. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia.
Waki T; Tamura G; Tsuchiya T; Sato K; Nishizuka S; Motoyama T
Am J Pathol; 2002 Aug; 161(2):399-403. PubMed ID: 12163364
[TBL] [Abstract][Full Text] [Related]
28. [Risk factor analysis and prediction model establishment of lymph node metastasis in remnant gastric cancer].
Wang W; Nie R; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):541-545. PubMed ID: 29774936
[TBL] [Abstract][Full Text] [Related]
29. CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients.
Dietrich D; Krispin M; Dietrich J; Fassbender A; Lewin J; Harbeck N; Schmitt M; Eppenberger-Castori S; Vuaroqueaux V; Spyratos F; Foekens JA; Lesche R; Martens JW
BMC Cancer; 2010 Jun; 10():247. PubMed ID: 20515469
[TBL] [Abstract][Full Text] [Related]
30. Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.
Kojima K; Nakamura T; Ohbu M; Katoh H; Ooizumi Y; Igarashi K; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Yokota K; Kosaka Y; Sato T; Watanabe M; Yamashita K
PLoS One; 2018; 13(5):e0194785. PubMed ID: 29746493
[TBL] [Abstract][Full Text] [Related]
31. DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer.
Ooki A; Yamashita K; Yamaguchi K; Mondal A; Nishimiya H; Watanabe M
Mol Cancer Res; 2013 Nov; 11(11):1362-74. PubMed ID: 23982217
[TBL] [Abstract][Full Text] [Related]
32. E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis.
Miyazaki T; Murayama Y; Shinomura Y; Yamamoto T; Watabe K; Tsutsui S; Kiyohara T; Tamura S; Hayashi N
Helicobacter; 2007 Oct; 12(5):523-31. PubMed ID: 17760721
[TBL] [Abstract][Full Text] [Related]
33. The endometrial cancer detection using non-invasive hypermethylation of
Cai B; Du J; Wang Y; Liu Z; Wang Y; Li L; Liu P; Wang L; Liu Q; Meng Z
Cytojournal; 2024; 21():15. PubMed ID: 38841418
[TBL] [Abstract][Full Text] [Related]
34. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
Graziano F; Arduini F; Ruzzo A; Mandolesi A; Bearzi I; Silva R; Muretto P; Testa E; Mari D; Magnani M; Scartozzi M; Cascinu S
Ann Oncol; 2004 Mar; 15(3):489-92. PubMed ID: 14998854
[TBL] [Abstract][Full Text] [Related]
35. Studying the expression rate and methylation of Reprimo gene in the blood of patients suffering from gastric cancer.
Abbasi A; Heydari S
Eur J Transl Myol; 2018 Apr; 28(2):7423. PubMed ID: 29991989
[TBL] [Abstract][Full Text] [Related]
36. Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma.
Choi JI; Cho EH; Kim SB; Kim R; Kwon J; Park M; Shin HJ; Ryu HS; Park SH; Lee KH
Ann Hepatobiliary Pancreat Surg; 2017 Nov; 21(4):181-187. PubMed ID: 29264579
[TBL] [Abstract][Full Text] [Related]
37. Detection of methylated CDO1 in plasma of colorectal cancer; a PCR study.
Yamashita K; Waraya M; Kim MS; Sidransky D; Katada N; Sato T; Nakamura T; Watanabe M
PLoS One; 2014; 9(12):e113546. PubMed ID: 25469504
[TBL] [Abstract][Full Text] [Related]
38. [The Role of Plasma CDO1 Methylation in the Early Diagnosis of Lung Cancer].
Wang P; Zhao H; Shi R; Liu X; Liu J; Ren F; Zhao Q; Zhang H; Li Y; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):314-320. PubMed ID: 32317090
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer.
Katoh H; Yamashita K; Waraya M; Margalit O; Ooki A; Tamaki H; Sakagami H; Kokubo K; Sidransky D; Watanabe M
Neoplasia; 2012 Jul; 14(7):559-71. PubMed ID: 22904674
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.
Yokoi K; Harada H; Yokota K; Ishii S; Tanaka T; Nishizawa N; Shimazu M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
Ann Surg Oncol; 2019 Feb; 26(2):406-414. PubMed ID: 30311169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
